Srikripa Devarakonda
Stock Analyst at Truist Securities
(0)
# 3162
Out of 5,218 analysts
54
Total ratings
36.84%
Success rate
6.94%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Edgewise Therapeutic... | Maintains: Strong Buy | 33 50 | 27.61 | 81.09% | 6 | Nov 27, 2024 | |
Scholar Rock Holding | Maintains: Strong Buy | 36 45 | 42.06 | 6.99% | 4 | Nov 25, 2024 | |
Regeneron Pharmaceut... | Maintains: Buy | 1137 1126 | 730.7 | 54.1% | 4 | Nov 1, 2024 | |
Kymera Therapeutics | Reiterates: Buy | 54 53 | 41.98 | 26.25% | 3 | Nov 1, 2024 | |
Eli Lilly | Maintains: Strong Buy | 1000 1033 | 789.07 | 30.91% | 3 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 210 215 | 173.5 | 23.92% | 1 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 54 54 | 5.64 | 857.45% | 1 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 83 74 | 68.61 | 7.86% | 8 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 60 | 41.15 | 45.81% | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 18 15 | 4.49 | 234.08% | 7 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 340 302 | 150.04 | 101.28% | 1 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 36 | 20.21 | 78.13% | 1 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 100 100 | 18.83 | 431.07% | 3 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 86 70 | 48.66 | 43.86% | 4 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 80 60 | 2.13 | 2716.9% | 2 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 38 | n/a | n/a | 3 | Mar 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 50 34 | n/a | n/a | 2 | Jun 3, 2021 |